The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Neumora Therapeutics Inc (NASDAQ: NMRA) closed at $1.71 in the last session, down -5.00% from day before closing price of $1.80. In other words, the price has decreased by -$5.00 from its previous closing price. On the day, 1.12 million shares were traded.
Ratios:
We take a closer look at NMRA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.98 and its Current Ratio is at 10.98. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on January 02, 2025, Downgraded its rating to Sector Perform and sets its target price to $4 from $29 previously.
On November 05, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $18 to $15.
On October 01, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.H.C. Wainwright initiated its Buy rating on October 01, 2024, with a $30 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when BERNS PAUL L sold 13,871 shares for $1.69 per share. The transaction valued at 23,468 led to the insider holds 7,405,004 shares of the business.
Milligan Michael Lee sold 1,978 shares of NMRA for $3,351 on Feb 18 ’25. The insider now owns 22,470 shares after completing the transaction at $1.69 per share. On Feb 18 ’25, another insider, Aurora Daljit Singh, who serves as the Chief Strategy Officer of the company, sold 8,565 shares for $1.68 each. As a result, the insider received 14,347 and left with 88,935 shares of the company.
Stock Price History:
Over the past 52 weeks, NMRA has reached a high of $21.00, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is -62.99%, while the 200-Day Moving Average is calculated to be -82.35%.
Shares Statistics:
A total of 160.48M shares are outstanding, with a floating share count of 56.39M. Insiders hold about 65.10% of the company’s shares, while institutions hold 37.39% stake in the company.
Earnings Estimates
The dynamic stock of Neumora Therapeutics Inc (NMRA) is currently being evaluated by a team of 6.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.39 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.52 and -$1.63 for the fiscal current year, implying an average EPS of -$1.6. EPS for the following year is -$1.55, with 7.0 analysts recommending between -$1.11 and -$1.94.
